Williamsson C, Danielsson P, Smith L
Department of Surgery and Oncology, Hospital of Halmstad, Halmstad, Sweden.
Phlebology. 2013 Mar;28(2):80-5. doi: 10.1258/phleb.2011.011136. Epub 2013 May 6.
This study aims to describe a technique for catheter-directed foam sclerotherapy (CDS) of great saphenous vein (GSV) insufficiency and report occlusion rate and patient satisfaction after a single treatment.
About 100 patients were included. The GSV was accessed at knee level. With the method of Tessari 10 mL sclerosant foam was made (2 mL 3% polidocanol and 8 mL air) and delivered along the GSV while the catheter was withdrawn. At two weeks and at one year after treatment the patients were evaluated.
CDS was successfully performed in 94 of the 100 patients. After one year, 84% of the patients were satisfied. Seventy percent of the GSV were completely occluded, 14% were partly occluded and 15% were recanalized. No serious side-effects occurred.
CDS is safe. Patient satisfaction is very satisfying and the occlusion rate is promising after a single treatment. Repeated treatments and technical development may achieve higher occlusion rates.
本研究旨在描述一种用于治疗大隐静脉功能不全的导管导向泡沫硬化疗法（CDS）技术，并报告单次治疗后的闭塞率和患者满意度。
纳入约100例患者。在膝关节水平处进入大隐静脉。采用泰萨里法制作10毫升硬化剂泡沫（2毫升3%聚多卡醇和8毫升空气），在回撤导管时沿大隐静脉注入。在治疗后两周和一年对患者进行评估。
100例患者中有94例成功进行了CDS。一年后，84%的患者表示满意。70%的大隐静脉完全闭塞，14%部分闭塞，15%再通。未发生严重副作用。
CDS是安全的。单次治疗后患者满意度很高，闭塞率也很可观。重复治疗和技术改进可能会实现更高的闭塞率。
